Exon 14 Deleted MET Receptor as a New Biomarker and Target in Cancers
Sign Up to like & getrecommendations! Published in 2017 at "Journal Of The National Cancer Institute"
DOI: 10.1093/jnci/djw262
Abstract: Inhibitors of the receptor tyrosine kinase (RTK) MET have been ineffective at treating cancer, possibly because of lack of knowledge that would allow selection of tumors likely to respond to this treatment. In contrast, specific… read more here.
Keywords: biomarker target; exon deleted; new biomarker; deleted met ... See more keywords